REFERENCES
- Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 2006; 69: 562–573
- Garrett S. C., Varney K. M., Weber D. J., Bresnick A. R. S100A4, a mediator of metastasis. J. Biol. Chem. 2006; 281: 677–680
- Helfman D. M., Kim E. J., Lukanidin E., Grigorian M. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br. J. Cancer 2005; 92: 1955–1958
- Bjornland K., Winberg J. O., Odegaard O. T., Hovig E., Loennechen T., Aasen A. O., Fodstad O., Maelandsmo G. M. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res. 1999; 59: 4702–4708
- Mathisen B., Lindstad R. I., Hansen J., El-Gewely S. A., Maelandsmo G. M., Hovig E., Fodstad O., Loennechen T., Winberg J. O. S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells. Clin. Exp. Metastasis 2003; 20: 701–711
- Gao X. N., Tang S. Q., Zhang X. F. S100A4 antisense oligodeoxynucleotide suppresses invasive potential of neuroblastoma cells. J. Pediatr. Surg. 2005; 40: 648–652
- Cui J. F., Liu Y. K., Zhang L. J., Shen H. L., Song H. Y., Dai Z., Yu Y. L., Zhang Y., Sun R. X., Chen J., Tang Z. Y., Yang P. Y. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro. Proteomics 2006; 6: 5953–5961
- Saleem M., Kweon M. H., Johnson J. J., Adhami V. M., Elcheva I., Khan N., Bin Hafeez B., Bhat K. M., Sarfaraz S., Reagan-Shaw S., Spiegelman V. S., Setaluri V., Mukhtar H. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc. Natl. Acad. Sci. USA 2006; 103: 14825–14830
- Schmidt-Hansen B., Ornas D., Grigorian M., Klingelhofer J., Tulchinsky E., Lukanidin E., Ambartsumian N. Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 2004; 23: 5487–5495
- Schmidt-Hansen B., Klingelhofer J., Grum-Schwensen B., Christensen A., Andresen S., Kruse C., Hansen T., Ambartsumian N., Lukanidin E., Grigorian M. Functional significance of metastasis-inducing S100A4(Mts1) in tumor-stroma interplay. J. Biol. Chem. 2004; 279: 24498–24504
- Senolt L., Grigorian M., Lukanidin E., Simmen B., Michel B. A., Pavelka K., Gay R. E., Gay S., Neidhart M. S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases. Ann. Rheum. Dis. 2006; 65: 1645–1648
- Yammani R. R., Carlson C. S., Bresnick A. R., Loeser R. F. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthr. Rheum. 2006; 54: 2901–2911
- Barraclough R. Calcium-binding protein S100A4 in health and disease. Biochim. Biophys. Acta. 1998; 1448: 190–199
- Maelandsmo G. M., Hovig E., Skrede M., Engebraaten O., Florenes V. A., Myklebost O., Grigorian M., Lukanidin E., Scanlon K. J., Fodstad O. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res. 1996; 56: 5490–5498